Stereospecific ligands and their complexes. Part X: Synthesis, characterization and in vitro antitumoral activity of platinum(IV) complexes with O,O′-dialkyl-(S,S)-ethylenediamine-N,N′-di-2-(4-methyl) pentanoate ligands

Inorganica Chimica Acta

Volumn 390, Issue , 2012, Pages 123-128

  Vujić, Jelena M ^a   Kaluerović, Goran N ^b   Zmejkovski, Bojana B ^c   Milovanović, Marija ^a   Volarević, Vladislav ^a   Arsenijević, Nebojša ^a   Stanojković, Tatjana P ^d   Trifunović, Srećko R ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Antitumoral activity; Apoptosis; Cell cycle; EDDA type ligands; Platinum(IV) complexes

Indexed keywords

CELL CULTURE; CELL DEATH; CHELATION; LIGANDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS (CHEMICAL);

13C NMR SPECTROSCOPY; ANALYSIS AND CHARACTERIZATION; ANTI-TUMORAL ACTIVITY; ANTICANCER ACTIVITIES; CELL CYCLE; CELL CYCLE ANALYSIS; LIGAND PRECURSORS; PLATINUM COMPLEXES;

PLATINUM COMPOUNDS;

EID: 84861157759     PISSN: 00201693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ica.2012.03.048     Document Type: Article

References (33)

1. E. Wong, and C.M. Giandomenico Chem. Rev. 99 1999 2451 2466
2. G. Natile, and M. Coluccia Coord. Chem. Rev. 383 2001 216 217
3. B. Rosenberg, L. Van Camp, and T. Krigas Nature 205 1965 698 699
4. B. Rosenberg, L. Van Camp, E.B. Grimley, and A.J. Thomson J. Biol. Chem. 242 1967 1347 1352
5. B. Rosenberg Platinum Met. Rev. 15 1971 42 51
6. G. Natile, and M. Coluccia Coord. Chem. Rev. 216 2001 383 410
7. J. Reedijk Chem. Commun. 7 1996 801 806
8. M.D. Hall, and T.W. Hambley Coord. Chem. Rev. 232 2002 49 67
9. Z.H. Siddik Oncogene 22 2003 7265 7279
10. M. Galanski, V.B. Arion, M.A. Jakupec, and B.K. Keppler Curr. Pharm. Des. 9 2003 2078 2089
11. C.X. Zhang, and S.J. Lippard Curr. Opin. Chem. Biol. 7 2003 481 489
12. L.R. Kelland, in: B. Lippert (Ed.), Cisplatin, Chemistry and Biochemistry of Leading Anticancer Drug, VHCA/Wiley-VCH, Weinheim, 1999, pp. 497-521.
13. T.W. Hambley, A.R. Battle, G.B. Decon, E.T. Lawrenz, G.D. Fallon, B.M. Gatehouse, L.K. Webster, and S. Rainone J. Inorg. Biochem. 77 1999 3 12
14. G.N. Kaluerović, G.A. Bogdanović, and T.J. Sabo J. Coord. Chem. 55 2002 817 822
15. L.R. Kelland Expert. Opin. Invest Drugs 9 2000 1373 1382
16. T.J. Sabo, G.N. Kaluerović, D. Poleti, Lj. Karanović, A. Boccarelli, F. Cannito, and G. Natile J. Inorg. Biochem. 98 2004 1378 1384
17. T.J. Sabo, G.N. Kaluerović, S.R. Grgurić-Šipka, F.W. Heinemann, and S.R. Trifunović Inorg. Chem. Commun. 7 2004 241 244
18. G.N. Kaluerović, H. Schmidt, S. Schwieger, Ch. Wagner, R. Paschke, A. Dietrich, T. Mueller, and D. Steinborn Inorg. Chim. Acta 361 2008 1395 1404
19. G.N. Kaluerović, H. Schmidt, D. Steinborn, T.J. Sabo, in: J.G. Hughes and A.J. Robinson (Eds.), Inorganic Biochemistry, Research Progress, Nova Science Publishers, Hauppauge, NY, 2008, pp. 305-326.
20. L.N. Schoenberg, D.W. Cooke, and C.F. Liu Inorg. Chem. 7 1968 2386 2393
21. J.M. Vujić, M. Cvijović, G.N. Kaluerović, M. Milovanović, B.B. Zmejkovski, V. Volarević, N. Arsenijević, T.J. Sabo, and S.R. Trifunović Eur. J. Med. Chem. 45 2010 3601 3606
22. B.B. Krajčinović, G.N. Kaluerović, D. Steinborn, H. Schmidt, Ch. Wagner, Ž. Žižak, Z.D. Juranić, S.R. Trifunović, and T.J. Sabo J. Inorg. Biochem. 102 2008 892 900
23. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, J.A. Montgomery Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H.P. Hratchian, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, P.Y. Ayala, K. Morokuma, G.A. Voth, P. Salvador, J.J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A.D. Daniels, M.C. Strain, O. Farkas, D.K. Malick, A.D. Rabuck, K. Raghavachari, J.B. Foresman, J.V. Ortiz, Q. Cui, A.G. Baboul, S. Clifford, J. Cioslowski, B.B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R.L. Martin, D.J. Fox, T. Keith, M.A. AlLaham, C.Y. Peng, A. Nanayakkara, M. Challacombe, P.M.W. Gill, B. Johnson, W. Chen, M.W. Wong, C. Gonzalez, J.A. Pople, GAUSSIAN 03, Revision C.02, Gaussian, Pople, J.A. Inc., Wallingford CT, 2004.
24. C. Adamo, and V. Barone Chem. Phys. Lett. 274 1997 242 250
25. T.H. Dunning Jr., P.J. Hay, in: Modern Theoretical Chemistry, vol. 3, Plenum, New York, 1976, pp. 1-28.
26. D. Andrae, U. Häusermann, M. Dolg, H. Stoll, and H. Preus Theor. Chem. Acc. 77 1990 123 141
27. T. Mosmann J. Immunol. Methods 65 1983 55 63
28. M. Ohno, and T. Abe J. Immunol. Methods 145 1991 199 203
29. J.A. Plumb, in: Cancer Cell Culture, Methods and Protocols. Cell Sensitivity Assays, The MTT Assay. Methods in Molecular Medicine, vol. 88, 2003, pp 165-169.
30. R.H. Clothier Methods Mol. Biol. 43 1995 109 118
31. C. Liedtke, J. Wang, A. Tordai, W.F. Symmans, G.N. Hortobagyi, L. Kiesel, K. Hess, K.A. Baggerly, K.R. Coombes, and L. Pusztai Breast Cancer Res. Treat. 121 2010 301 309
32. H. Varbanov, S.M. Valiahdi, A.A. Legin, M.A. Jakupec, A. Roller, M. Galanski, and B.K. Keppler Eur. J. Med. Chem. 46 2011 5456 5464
33. T. Drewa, A. Wozniak, and G. Drewa Med. Sci. Monit. 7 2001 680 686